nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.156	0.286	CiPCiCtD
Cyclosporine—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.122	0.223	CiPCiCtD
Cyclosporine—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0946	0.173	CiPCiCtD
Cyclosporine—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.087	0.159	CiPCiCtD
Cyclosporine—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.087	0.159	CiPCiCtD
Cyclosporine—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.00869	0.0284	CbGbCtD
Cyclosporine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.00859	0.0281	CbGbCtD
Cyclosporine—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.00796	0.026	CbGbCtD
Cyclosporine—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0075	0.0245	CbGbCtD
Cyclosporine—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0067	0.0219	CbGbCtD
Cyclosporine—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.00659	0.0215	CbGbCtD
Cyclosporine—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.00659	0.0215	CbGbCtD
Cyclosporine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.00651	0.0213	CbGbCtD
Cyclosporine—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0065	0.0213	CbGbCtD
Cyclosporine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.00632	0.0207	CbGbCtD
Cyclosporine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.00614	0.0201	CbGbCtD
Cyclosporine—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.00588	0.0192	CbGbCtD
Cyclosporine—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.00588	0.0192	CbGbCtD
Cyclosporine—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.00555	0.0182	CbGbCtD
Cyclosporine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.00555	0.0181	CbGbCtD
Cyclosporine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.00555	0.0181	CbGbCtD
Cyclosporine—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.00488	0.016	CbGbCtD
Cyclosporine—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.00488	0.0159	CbGbCtD
Cyclosporine—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.00488	0.0159	CbGbCtD
Cyclosporine—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.00487	0.0159	CbGbCtD
Cyclosporine—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00441	0.0144	CbGbCtD
Cyclosporine—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00441	0.0144	CbGbCtD
Cyclosporine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0043	0.014	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0043	0.014	CbGbCtD
Cyclosporine—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.00423	0.0138	CbGbCtD
Cyclosporine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00371	0.0121	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00371	0.0121	CbGbCtD
Cyclosporine—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.00362	0.0118	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0036	0.0118	CbGbCtD
Cyclosporine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0036	0.0118	CbGbCtD
Cyclosporine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00356	0.0116	CbGbCtD
Cyclosporine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00342	0.0112	CbGbCtD
Cyclosporine—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.00327	0.0107	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.00326	0.0106	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.00326	0.0106	CbGbCtD
Cyclosporine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.00326	0.0106	CbGbCtD
Cyclosporine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.00326	0.0106	CbGbCtD
Cyclosporine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00322	0.0105	CbGbCtD
Cyclosporine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00322	0.0105	CbGbCtD
Cyclosporine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0031	0.0101	CbGbCtD
Cyclosporine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0031	0.0101	CbGbCtD
Cyclosporine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00306	0.00999	CbGbCtD
Cyclosporine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00287	0.0094	CbGbCtD
Cyclosporine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00278	0.00909	CbGbCtD
Cyclosporine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0027	0.00883	CbGbCtD
Cyclosporine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00265	0.00865	CbGbCtD
Cyclosporine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0026	0.0085	CbGbCtD
Cyclosporine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0026	0.0085	CbGbCtD
Cyclosporine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00254	0.00831	CbGbCtD
Cyclosporine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00244	0.00798	CbGbCtD
Cyclosporine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.00798	CbGbCtD
Cyclosporine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00239	0.00781	CbGbCtD
Cyclosporine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00239	0.00781	CbGbCtD
Cyclosporine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00235	0.00768	CbGbCtD
Cyclosporine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00235	0.00768	CbGbCtD
Cyclosporine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.0076	CbGbCtD
Cyclosporine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00232	0.00758	CbGbCtD
Cyclosporine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00225	0.00736	CbGbCtD
Cyclosporine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00734	CbGbCtD
Cyclosporine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00218	0.00714	CbGbCtD
Cyclosporine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00218	0.00714	CbGbCtD
Cyclosporine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00218	0.00712	CbGbCtD
Cyclosporine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00216	0.00706	CbGbCtD
Cyclosporine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00216	0.00706	CbGbCtD
Cyclosporine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0021	0.00686	CbGbCtD
Cyclosporine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00198	0.00646	CbGbCtD
Cyclosporine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00198	0.00646	CbGbCtD
Cyclosporine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00644	CbGbCtD
Cyclosporine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00644	CbGbCtD
Cyclosporine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00189	0.00617	CbGbCtD
Cyclosporine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00187	0.0061	CbGbCtD
Cyclosporine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00181	0.00592	CbGbCtD
Cyclosporine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00181	0.00592	CbGbCtD
Cyclosporine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00176	0.00575	CbGbCtD
Cyclosporine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00558	CbGbCtD
Cyclosporine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00166	0.00541	CbGbCtD
Cyclosporine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.00535	CbGbCtD
Cyclosporine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00535	CbGbCtD
Cyclosporine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00159	0.0052	CbGbCtD
Cyclosporine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.0052	CbGbCtD
Cyclosporine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00513	CbGbCtD
Cyclosporine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.00498	CbGbCtD
Cyclosporine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0015	0.0049	CbGbCtD
Cyclosporine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.0049	CbGbCtD
Cyclosporine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00483	CbGbCtD
Cyclosporine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00139	0.00454	CbGbCtD
Cyclosporine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00139	0.00454	CbGbCtD
Cyclosporine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00126	0.00411	CbGbCtD
Cyclosporine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00411	CbGbCtD
Cyclosporine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00385	CbGbCtD
Cyclosporine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00355	CbGbCtD
Cyclosporine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00344	CbGbCtD
Cyclosporine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.000952	0.00311	CbGbCtD
Cyclosporine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.000952	0.00311	CbGbCtD
Cyclosporine—PPID—blood plasma—acquired immunodeficiency syndrome	0.000919	0.0262	CbGeAlD
Cyclosporine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.000913	0.00298	CbGbCtD
Cyclosporine—PPP3CA—blood plasma—acquired immunodeficiency syndrome	0.00064	0.0182	CbGeAlD
Cyclosporine—PPID—retina—acquired immunodeficiency syndrome	0.000503	0.0143	CbGeAlD
Cyclosporine—CAMLG—retina—acquired immunodeficiency syndrome	0.000496	0.0141	CbGeAlD
Cyclosporine—FKBP1B—lung—acquired immunodeficiency syndrome	0.000484	0.0138	CbGeAlD
Cyclosporine—FKBP4—skin of body—acquired immunodeficiency syndrome	0.000479	0.0136	CbGeAlD
Cyclosporine—PPIA—retina—acquired immunodeficiency syndrome	0.000452	0.0129	CbGeAlD
Cyclosporine—FKBP1B—nervous system—acquired immunodeficiency syndrome	0.000448	0.0128	CbGeAlD
Cyclosporine—FKBP1B—central nervous system—acquired immunodeficiency syndrome	0.000431	0.0123	CbGeAlD
Cyclosporine—FKBP1A—blood plasma—acquired immunodeficiency syndrome	0.000425	0.0121	CbGeAlD
Cyclosporine—FKBP4—lymphoid tissue—acquired immunodeficiency syndrome	0.000388	0.0111	CbGeAlD
Cyclosporine—SLC10A2—digestive system—acquired immunodeficiency syndrome	0.000386	0.011	CbGeAlD
Cyclosporine—FKBP4—digestive system—acquired immunodeficiency syndrome	0.000383	0.0109	CbGeAlD
Cyclosporine—SLC10A2—blood—acquired immunodeficiency syndrome	0.000368	0.0105	CbGeAlD
Cyclosporine—PPIF—retina—acquired immunodeficiency syndrome	0.000366	0.0104	CbGeAlD
Cyclosporine—FKBP4—blood—acquired immunodeficiency syndrome	0.000365	0.0104	CbGeAlD
Cyclosporine—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.000361	0.0103	CbGeAlD
Cyclosporine—CAMLG—lymphoid tissue—acquired immunodeficiency syndrome	0.000353	0.0101	CbGeAlD
Cyclosporine—FKBP4—spinal cord—acquired immunodeficiency syndrome	0.000351	0.01	CbGeAlD
Cyclosporine—PPP3CA—retina—acquired immunodeficiency syndrome	0.00035	0.00999	CbGeAlD
Cyclosporine—FKBP1B—brain—acquired immunodeficiency syndrome	0.000342	0.00976	CbGeAlD
Cyclosporine—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.000342	0.00976	CbGeAlD
Cyclosporine—SLC10A2—vagina—acquired immunodeficiency syndrome	0.000341	0.00973	CbGeAlD
Cyclosporine—PPID—blood—acquired immunodeficiency syndrome	0.000337	0.0096	CbGeAlD
Cyclosporine—CAMLG—blood—acquired immunodeficiency syndrome	0.000332	0.00946	CbGeAlD
Cyclosporine—FKBP1B—lymph node—acquired immunodeficiency syndrome	0.000331	0.00943	CbGeAlD
Cyclosporine—PPID—bone marrow—acquired immunodeficiency syndrome	0.000326	0.00929	CbGeAlD
Cyclosporine—PPID—spinal cord—acquired immunodeficiency syndrome	0.000324	0.00925	CbGeAlD
Cyclosporine—PPIF—skin of body—acquired immunodeficiency syndrome	0.000321	0.00916	CbGeAlD
Cyclosporine—CAMLG—bone marrow—acquired immunodeficiency syndrome	0.000321	0.00915	CbGeAlD
Cyclosporine—FKBP4—lung—acquired immunodeficiency syndrome	0.00032	0.00912	CbGeAlD
Cyclosporine—CAMLG—spinal cord—acquired immunodeficiency syndrome	0.00032	0.00912	CbGeAlD
Cyclosporine—PPID—vagina—acquired immunodeficiency syndrome	0.000312	0.0089	CbGeAlD
Cyclosporine—CAMLG—vagina—acquired immunodeficiency syndrome	0.000308	0.00877	CbGeAlD
Cyclosporine—PPIB—skin of body—acquired immunodeficiency syndrome	0.000306	0.00872	CbGeAlD
Cyclosporine—PPIA—blood—acquired immunodeficiency syndrome	0.000302	0.00862	CbGeAlD
Cyclosporine—FKBP4—nervous system—acquired immunodeficiency syndrome	0.000296	0.00844	CbGeAlD
Cyclosporine—PPID—lung—acquired immunodeficiency syndrome	0.000295	0.00841	CbGeAlD
Cyclosporine—PPIA—bone marrow—acquired immunodeficiency syndrome	0.000292	0.00834	CbGeAlD
Cyclosporine—PPIA—spinal cord—acquired immunodeficiency syndrome	0.000291	0.0083	CbGeAlD
Cyclosporine—CAMLG—lung—acquired immunodeficiency syndrome	0.000291	0.00829	CbGeAlD
Cyclosporine—FKBP4—central nervous system—acquired immunodeficiency syndrome	0.000285	0.00813	CbGeAlD
Cyclosporine—PPIA—vagina—acquired immunodeficiency syndrome	0.00028	0.00799	CbGeAlD
Cyclosporine—PPID—nervous system—acquired immunodeficiency syndrome	0.000273	0.00779	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	0.00027	0.0104	CbGpPWpGaD
Cyclosporine—CAMLG—nervous system—acquired immunodeficiency syndrome	0.000269	0.00768	CbGeAlD
Cyclosporine—PPIA—Late Phase of HIV Life Cycle—CCNT1—acquired immunodeficiency syndrome	0.000268	0.0103	CbGpPWpGaD
Cyclosporine—PPIA—lung—acquired immunodeficiency syndrome	0.000265	0.00755	CbGeAlD
Cyclosporine—PPID—central nervous system—acquired immunodeficiency syndrome	0.000263	0.0075	CbGeAlD
Cyclosporine—PPIA—Host Interactions of HIV factors—CCNT1—acquired immunodeficiency syndrome	0.000263	0.0101	CbGpPWpGaD
Cyclosporine—SLC10A1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00026	0.01	CbGpPWpGaD
Cyclosporine—CAMLG—central nervous system—acquired immunodeficiency syndrome	0.000259	0.00739	CbGeAlD
Cyclosporine—PPIF—digestive system—acquired immunodeficiency syndrome	0.000257	0.00732	CbGeAlD
Cyclosporine—PPP3CA—lymphoid tissue—acquired immunodeficiency syndrome	0.000249	0.0071	CbGeAlD
Cyclosporine—PPIB—lymphoid tissue—acquired immunodeficiency syndrome	0.000248	0.00706	CbGeAlD
Cyclosporine—PPIA—HIV Life Cycle—CCNT1—acquired immunodeficiency syndrome	0.000247	0.00952	CbGpPWpGaD
Cyclosporine—PPP3CA—digestive system—acquired immunodeficiency syndrome	0.000246	0.00701	CbGeAlD
Cyclosporine—PPIF—blood—acquired immunodeficiency syndrome	0.000245	0.00698	CbGeAlD
Cyclosporine—PPIB—digestive system—acquired immunodeficiency syndrome	0.000245	0.00697	CbGeAlD
Cyclosporine—PPIF—bone marrow—acquired immunodeficiency syndrome	0.000237	0.00675	CbGeAlD
Cyclosporine—PPIF—spinal cord—acquired immunodeficiency syndrome	0.000236	0.00672	CbGeAlD
Cyclosporine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000235	0.0067	CbGeAlD
Cyclosporine—PPP3CA—blood—acquired immunodeficiency syndrome	0.000234	0.00668	CbGeAlD
Cyclosporine—PPIB—blood—acquired immunodeficiency syndrome	0.000233	0.00664	CbGeAlD
Cyclosporine—FKBP1A—retina—acquired immunodeficiency syndrome	0.000233	0.00664	CbGeAlD
Cyclosporine—PPIF—vagina—acquired immunodeficiency syndrome	0.000227	0.00647	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—acquired immunodeficiency syndrome	0.000227	0.00647	CbGeAlD
Cyclosporine—FKBP4—brain—acquired immunodeficiency syndrome	0.000226	0.00645	CbGeAlD
Cyclosporine—PPP3CA—spinal cord—acquired immunodeficiency syndrome	0.000226	0.00644	CbGeAlD
Cyclosporine—PPIB—bone marrow—acquired immunodeficiency syndrome	0.000225	0.00643	CbGeAlD
Cyclosporine—PPIB—spinal cord—acquired immunodeficiency syndrome	0.000225	0.0064	CbGeAlD
Cyclosporine—FKBP4—lymph node—acquired immunodeficiency syndrome	0.000219	0.00624	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.000218	0.00841	CbGpPWpGaD
Cyclosporine—PPP3CA—vagina—acquired immunodeficiency syndrome	0.000217	0.00619	CbGeAlD
Cyclosporine—PPIB—vagina—acquired immunodeficiency syndrome	0.000216	0.00616	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.000216	0.00831	CbGpPWpGaD
Cyclosporine—PPIF—lung—acquired immunodeficiency syndrome	0.000215	0.00612	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.000212	0.00818	CbGpPWpGaD
Cyclosporine—SLC10A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000211	0.00813	CbGpPWpGaD
Cyclosporine—SLC10A1—digestive system—acquired immunodeficiency syndrome	0.000209	0.00596	CbGeAlD
Cyclosporine—PPID—brain—acquired immunodeficiency syndrome	0.000209	0.00596	CbGeAlD
Cyclosporine—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000207	0.00589	CbGeAlD
Cyclosporine—CAMLG—brain—acquired immunodeficiency syndrome	0.000206	0.00587	CbGeAlD
Cyclosporine—PPP3CA—lung—acquired immunodeficiency syndrome	0.000205	0.00586	CbGeAlD
Cyclosporine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000205	0.00585	CbGeAlD
Cyclosporine—FKBP1A—skin of body—acquired immunodeficiency syndrome	0.000204	0.00583	CbGeAlD
Cyclosporine—PPIB—lung—acquired immunodeficiency syndrome	0.000204	0.00582	CbGeAlD
Cyclosporine—PPID—lymph node—acquired immunodeficiency syndrome	0.000202	0.00575	CbGeAlD
Cyclosporine—PPIA—HIV Infection—APOBEC3G—acquired immunodeficiency syndrome	0.000201	0.00773	CbGpPWpGaD
Cyclosporine—CAMLG—lymph node—acquired immunodeficiency syndrome	0.000199	0.00567	CbGeAlD
Cyclosporine—PPIF—nervous system—acquired immunodeficiency syndrome	0.000199	0.00566	CbGeAlD
Cyclosporine—PPIF—central nervous system—acquired immunodeficiency syndrome	0.000191	0.00545	CbGeAlD
Cyclosporine—PPP3CA—nervous system—acquired immunodeficiency syndrome	0.00019	0.00542	CbGeAlD
Cyclosporine—PPIB—nervous system—acquired immunodeficiency syndrome	0.000189	0.00539	CbGeAlD
Cyclosporine—PPIA—brain—acquired immunodeficiency syndrome	0.000188	0.00535	CbGeAlD
Cyclosporine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000185	0.00528	CbGeAlD
Cyclosporine—PPP3CA—central nervous system—acquired immunodeficiency syndrome	0.000183	0.00522	CbGeAlD
Cyclosporine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000182	0.00519	CbGeAlD
Cyclosporine—PPIB—central nervous system—acquired immunodeficiency syndrome	0.000182	0.00519	CbGeAlD
Cyclosporine—PPIA—lymph node—acquired immunodeficiency syndrome	0.000181	0.00517	CbGeAlD
Cyclosporine—PPP3CA—BCR signaling pathway—CD79A—acquired immunodeficiency syndrome	0.000177	0.00681	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000173	0.00665	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—CCNT1—acquired immunodeficiency syndrome	0.000171	0.00657	CbGpPWpGaD
Cyclosporine—FKBP1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000165	0.00472	CbGeAlD
Cyclosporine—FKBP1A—digestive system—acquired immunodeficiency syndrome	0.000163	0.00466	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	0.000163	0.00629	CbGpPWpGaD
Cyclosporine—SLC10A1—nervous system—acquired immunodeficiency syndrome	0.000162	0.00461	CbGeAlD
Cyclosporine—SLC10A1—central nervous system—acquired immunodeficiency syndrome	0.000156	0.00444	CbGeAlD
Cyclosporine—FKBP1A—blood—acquired immunodeficiency syndrome	0.000156	0.00444	CbGeAlD
Cyclosporine—ABCB11—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000153	0.00591	CbGpPWpGaD
Cyclosporine—PPP3R2—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000153	0.00588	CbGpPWpGaD
Cyclosporine—PPIF—brain—acquired immunodeficiency syndrome	0.000152	0.00433	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—acquired immunodeficiency syndrome	0.000151	0.0043	CbGeAlD
Cyclosporine—FKBP1A—spinal cord—acquired immunodeficiency syndrome	0.00015	0.00428	CbGeAlD
Cyclosporine—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000148	0.00569	CbGpPWpGaD
Cyclosporine—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—IL2—acquired immunodeficiency syndrome	0.000147	0.00567	CbGpPWpGaD
Cyclosporine—ABCC3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000147	0.00566	CbGpPWpGaD
Cyclosporine—PPIF—lymph node—acquired immunodeficiency syndrome	0.000147	0.00418	CbGeAlD
Cyclosporine—PPP3CA—brain—acquired immunodeficiency syndrome	0.000145	0.00415	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	0.000145	0.00559	CbGpPWpGaD
Cyclosporine—PPIB—brain—acquired immunodeficiency syndrome	0.000145	0.00412	CbGeAlD
Cyclosporine—FKBP1A—vagina—acquired immunodeficiency syndrome	0.000144	0.00411	CbGeAlD
Cyclosporine—PPP3CA—lymph node—acquired immunodeficiency syndrome	0.000141	0.00401	CbGeAlD
Cyclosporine—PPIB—lymph node—acquired immunodeficiency syndrome	0.00014	0.00398	CbGeAlD
Cyclosporine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000139	0.00396	CbGeAlD
Cyclosporine—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000139	0.00395	CbGeAlD
Cyclosporine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000137	0.0039	CbGeAlD
Cyclosporine—FKBP1A—lung—acquired immunodeficiency syndrome	0.000137	0.00389	CbGeAlD
Cyclosporine—SLC10A1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000136	0.00524	CbGpPWpGaD
Cyclosporine—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000133	0.00378	CbGeAlD
Cyclosporine—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000132	0.00377	CbGeAlD
Cyclosporine—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000132	0.00375	CbGeAlD
Cyclosporine—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000131	0.00373	CbGeAlD
Cyclosporine—PPIA—HIV Life Cycle—CXCR4—acquired immunodeficiency syndrome	0.00013	0.005	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000129	0.00495	CbGpPWpGaD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000128	0.00494	CbGpPWpGaD
Cyclosporine—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000128	0.00493	CbGpPWpGaD
Cyclosporine—FKBP1A—nervous system—acquired immunodeficiency syndrome	0.000126	0.0036	CbGeAlD
Cyclosporine—ABCC3—blood—acquired immunodeficiency syndrome	0.000125	0.00357	CbGeAlD
Cyclosporine—ABCC10—blood—acquired immunodeficiency syndrome	0.000125	0.00356	CbGeAlD
Cyclosporine—SLC10A1—brain—acquired immunodeficiency syndrome	0.000124	0.00353	CbGeAlD
Cyclosporine—FKBP1A—central nervous system—acquired immunodeficiency syndrome	0.000122	0.00347	CbGeAlD
Cyclosporine—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000121	0.00344	CbGeAlD
Cyclosporine—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.00012	0.00343	CbGeAlD
Cyclosporine—ABCC10—vagina—acquired immunodeficiency syndrome	0.000116	0.0033	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000114	0.00439	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000113	0.00436	CbGpPWpGaD
Cyclosporine—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000113	0.00322	CbGeAlD
Cyclosporine—ABCC3—lung—acquired immunodeficiency syndrome	0.00011	0.00313	CbGeAlD
Cyclosporine—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00011	0.00422	CbGpPWpGaD
Cyclosporine—ABCC10—lung—acquired immunodeficiency syndrome	0.000109	0.00312	CbGeAlD
Cyclosporine—SLC22A6—brain—acquired immunodeficiency syndrome	0.000106	0.00303	CbGeAlD
Cyclosporine—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000105	0.003	CbGeAlD
Cyclosporine—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000104	0.00295	CbGeAlD
Cyclosporine—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000102	0.0029	CbGeAlD
Cyclosporine—ABCC2—blood—acquired immunodeficiency syndrome	0.0001	0.00286	CbGeAlD
Cyclosporine—FKBP1A—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	9.97e-05	0.00384	CbGpPWpGaD
Cyclosporine—ABCB1—blood plasma—acquired immunodeficiency syndrome	9.83e-05	0.0028	CbGeAlD
Cyclosporine—ABCC3—central nervous system—acquired immunodeficiency syndrome	9.8e-05	0.00279	CbGeAlD
Cyclosporine—PPIA—Platelet degranulation—ALB—acquired immunodeficiency syndrome	9.7e-05	0.00373	CbGpPWpGaD
Cyclosporine—FKBP1A—brain—acquired immunodeficiency syndrome	9.66e-05	0.00275	CbGeAlD
Cyclosporine—SLCO1A2—lung—acquired immunodeficiency syndrome	9.43e-05	0.00269	CbGeAlD
Cyclosporine—FKBP1A—lymph node—acquired immunodeficiency syndrome	9.34e-05	0.00266	CbGeAlD
Cyclosporine—PPIA—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	9.24e-05	0.00356	CbGpPWpGaD
Cyclosporine—CYP2C19—digestive system—acquired immunodeficiency syndrome	9.04e-05	0.00258	CbGeAlD
Cyclosporine—PPIA—HIV Infection—CXCR4—acquired immunodeficiency syndrome	8.97e-05	0.00345	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	8.92e-05	0.00343	CbGpPWpGaD
Cyclosporine—PPIA—HIV Life Cycle—CCR5—acquired immunodeficiency syndrome	8.9e-05	0.00343	CbGpPWpGaD
Cyclosporine—ABCC1—blood—acquired immunodeficiency syndrome	8.82e-05	0.00252	CbGeAlD
Cyclosporine—SLCO1A2—nervous system—acquired immunodeficiency syndrome	8.73e-05	0.00249	CbGeAlD
Cyclosporine—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TNF—acquired immunodeficiency syndrome	8.63e-05	0.00332	CbGpPWpGaD
Cyclosporine—CYP2C19—blood—acquired immunodeficiency syndrome	8.61e-05	0.00245	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	8.53e-05	0.00328	CbGpPWpGaD
Cyclosporine—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	8.4e-05	0.0024	CbGeAlD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	8.35e-05	0.00322	CbGpPWpGaD
Cyclosporine—ABCC1—vagina—acquired immunodeficiency syndrome	8.18e-05	0.00233	CbGeAlD
Cyclosporine—ABCB11—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	8.02e-05	0.00309	CbGpPWpGaD
Cyclosporine—CYP2C19—vagina—acquired immunodeficiency syndrome	7.98e-05	0.00227	CbGeAlD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	7.81e-05	0.00301	CbGpPWpGaD
Cyclosporine—ABCC3—brain—acquired immunodeficiency syndrome	7.78e-05	0.00222	CbGeAlD
Cyclosporine—ABCC10—brain—acquired immunodeficiency syndrome	7.74e-05	0.00221	CbGeAlD
Cyclosporine—ABCC1—lung—acquired immunodeficiency syndrome	7.74e-05	0.00221	CbGeAlD
Cyclosporine—ABCC3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	7.69e-05	0.00296	CbGpPWpGaD
Cyclosporine—ABCC3—lymph node—acquired immunodeficiency syndrome	7.52e-05	0.00214	CbGeAlD
Cyclosporine—CYP2C8—blood—acquired immunodeficiency syndrome	7.51e-05	0.00214	CbGeAlD
Cyclosporine—ABCC10—lymph node—acquired immunodeficiency syndrome	7.48e-05	0.00213	CbGeAlD
Cyclosporine—ABCG2—blood—acquired immunodeficiency syndrome	7.31e-05	0.00208	CbGeAlD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	7.29e-05	0.00281	CbGpPWpGaD
Cyclosporine—CYP3A5—digestive system—acquired immunodeficiency syndrome	7.12e-05	0.00203	CbGeAlD
Cyclosporine—ABCG2—bone marrow—acquired immunodeficiency syndrome	7.07e-05	0.00201	CbGeAlD
Cyclosporine—ABCG2—spinal cord—acquired immunodeficiency syndrome	7.04e-05	0.00201	CbGeAlD
Cyclosporine—CYP2C9—digestive system—acquired immunodeficiency syndrome	7.01e-05	0.002	CbGeAlD
Cyclosporine—CYP2C8—vagina—acquired immunodeficiency syndrome	6.96e-05	0.00199	CbGeAlD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	6.91e-05	0.00266	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	6.83e-05	0.00263	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	6.8e-05	0.00262	CbGpPWpGaD
Cyclosporine—CYP3A5—blood—acquired immunodeficiency syndrome	6.78e-05	0.00193	CbGeAlD
Cyclosporine—ABCG2—vagina—acquired immunodeficiency syndrome	6.77e-05	0.00193	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	6.72e-05	0.00259	CbGpPWpGaD
Cyclosporine—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	6.69e-05	0.00258	CbGpPWpGaD
Cyclosporine—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	6.68e-05	0.00257	CbGpPWpGaD
Cyclosporine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	6.68e-05	0.00257	CbGpPWpGaD
Cyclosporine—CYP2C9—blood—acquired immunodeficiency syndrome	6.67e-05	0.0019	CbGeAlD
Cyclosporine—SLCO1A2—brain—acquired immunodeficiency syndrome	6.67e-05	0.0019	CbGeAlD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	6.6e-05	0.00254	CbGpPWpGaD
Cyclosporine—PPP3CA—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	6.42e-05	0.00247	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	6.41e-05	0.00247	CbGpPWpGaD
Cyclosporine—ABCG2—lung—acquired immunodeficiency syndrome	6.4e-05	0.00183	CbGeAlD
Cyclosporine—CYP3A5—vagina—acquired immunodeficiency syndrome	6.29e-05	0.00179	CbGeAlD
Cyclosporine—PPIA—HIV Infection—CCR5—acquired immunodeficiency syndrome	6.15e-05	0.00237	CbGpPWpGaD
Cyclosporine—ABCC2—lymph node—acquired immunodeficiency syndrome	6.01e-05	0.00171	CbGeAlD
Cyclosporine—CYP3A5—lung—acquired immunodeficiency syndrome	5.94e-05	0.00169	CbGeAlD
Cyclosporine—PPIA—Host Interactions of HIV factors—CD4—acquired immunodeficiency syndrome	5.94e-05	0.00229	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—TAT—acquired immunodeficiency syndrome	5.93e-05	0.00228	CbGpPWpGaD
Cyclosporine—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	5.73e-05	0.0022	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	5.61e-05	0.00216	CbGpPWpGaD
Cyclosporine—PPIA—HIV Life Cycle—CD4—acquired immunodeficiency syndrome	5.59e-05	0.00215	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	5.48e-05	0.00211	CbGpPWpGaD
Cyclosporine—ABCC1—brain—acquired immunodeficiency syndrome	5.48e-05	0.00156	CbGeAlD
Cyclosporine—PPP3CA—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	5.39e-05	0.00207	CbGpPWpGaD
Cyclosporine—ABCB1—retina—acquired immunodeficiency syndrome	5.38e-05	0.00153	CbGeAlD
Cyclosporine—CYP3A4—digestive system—acquired immunodeficiency syndrome	5.34e-05	0.00152	CbGeAlD
Cyclosporine—ABCC1—lymph node—acquired immunodeficiency syndrome	5.29e-05	0.00151	CbGeAlD
Cyclosporine—CYP2D6—digestive system—acquired immunodeficiency syndrome	5.26e-05	0.0015	CbGeAlD
Cyclosporine—CYP3A4—blood—acquired immunodeficiency syndrome	5.09e-05	0.00145	CbGeAlD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	5.05e-05	0.00195	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.04e-05	0.00194	CbGpPWpGaD
Cyclosporine—CYP2D6—blood—acquired immunodeficiency syndrome	5.01e-05	0.00143	CbGeAlD
Cyclosporine—PPIA—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.92e-05	0.00189	CbGpPWpGaD
Cyclosporine—PPP3CA—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	4.81e-05	0.00185	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	4.79e-05	0.00184	CbGpPWpGaD
Cyclosporine—CYP2C8—brain—acquired immunodeficiency syndrome	4.66e-05	0.00133	CbGeAlD
Cyclosporine—PPP3CA—Innate Immune System—MBL2—acquired immunodeficiency syndrome	4.61e-05	0.00177	CbGpPWpGaD
Cyclosporine—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	4.58e-05	0.00176	CbGpPWpGaD
Cyclosporine—ABCG2—brain—acquired immunodeficiency syndrome	4.53e-05	0.00129	CbGeAlD
Cyclosporine—FKBP1B—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.52e-05	0.00174	CbGpPWpGaD
Cyclosporine—ABCG2—lymph node—acquired immunodeficiency syndrome	4.38e-05	0.00125	CbGeAlD
Cyclosporine—PPIA—Hemostasis—IFNA1—acquired immunodeficiency syndrome	4.35e-05	0.00167	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	4.3e-05	0.00166	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.3e-05	0.00165	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CCNT1—acquired immunodeficiency syndrome	4.18e-05	0.00161	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	4.18e-05	0.00161	CbGpPWpGaD
Cyclosporine—CYP3A4—nervous system—acquired immunodeficiency syndrome	4.13e-05	0.00118	CbGeAlD
Cyclosporine—PPP3CA—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	4.12e-05	0.00159	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.12e-05	0.00159	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—APOBEC3G—acquired immunodeficiency syndrome	4.09e-05	0.00157	CbGpPWpGaD
Cyclosporine—CYP2D6—nervous system—acquired immunodeficiency syndrome	4.07e-05	0.00116	CbGeAlD
Cyclosporine—PPP3CA—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	4.02e-05	0.00155	CbGpPWpGaD
Cyclosporine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	3.98e-05	0.00113	CbGeAlD
Cyclosporine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	3.91e-05	0.00112	CbGeAlD
Cyclosporine—PPIA—HIV Infection—CD4—acquired immunodeficiency syndrome	3.86e-05	0.00149	CbGpPWpGaD
Cyclosporine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	3.83e-05	0.00109	CbGeAlD
Cyclosporine—SLC10A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.82e-05	0.00147	CbGpPWpGaD
Cyclosporine—ABCB1—digestive system—acquired immunodeficiency syndrome	3.78e-05	0.00108	CbGeAlD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.73e-05	0.00144	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	3.71e-05	0.00143	CbGpPWpGaD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	3.61e-05	0.00139	CbGpPWpGaD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	3.61e-05	0.00139	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CCR2—acquired immunodeficiency syndrome	3.61e-05	0.00139	CbGpPWpGaD
Cyclosporine—ABCB1—blood—acquired immunodeficiency syndrome	3.6e-05	0.00103	CbGeAlD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.59e-05	0.00138	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	3.49e-05	0.00134	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	3.49e-05	0.00134	CbGpPWpGaD
Cyclosporine—ABCB1—bone marrow—acquired immunodeficiency syndrome	3.49e-05	0.000994	CbGeAlD
Cyclosporine—PPP3CA—Disease—CCNT1—acquired immunodeficiency syndrome	3.48e-05	0.00134	CbGpPWpGaD
Cyclosporine—ABCB1—spinal cord—acquired immunodeficiency syndrome	3.47e-05	0.000989	CbGeAlD
Cyclosporine—PPIA—Hemostasis—CSF2—acquired immunodeficiency syndrome	3.4e-05	0.00131	CbGpPWpGaD
Cyclosporine—FKBP4—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	3.35e-05	0.00129	CbGpPWpGaD
Cyclosporine—ABCB1—vagina—acquired immunodeficiency syndrome	3.34e-05	0.000952	CbGeAlD
Cyclosporine—PPP3CA—Immune System—ACTG1—acquired immunodeficiency syndrome	3.27e-05	0.00126	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	3.25e-05	0.00125	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.25e-05	0.00125	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.23e-05	0.00124	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.17e-05	0.00122	CbGpPWpGaD
Cyclosporine—ABCB1—lung—acquired immunodeficiency syndrome	3.16e-05	0.0009	CbGeAlD
Cyclosporine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	3.13e-05	0.0012	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.12e-05	0.0012	CbGpPWpGaD
Cyclosporine—CYP2D6—brain—acquired immunodeficiency syndrome	3.11e-05	0.000886	CbGeAlD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.07e-05	0.00118	CbGpPWpGaD
Cyclosporine—ABCB1—nervous system—acquired immunodeficiency syndrome	2.92e-05	0.000834	CbGeAlD
Cyclosporine—Pruritus—Stavudine—acquired immunodeficiency syndrome	2.85e-05	0.00033	CcSEcCtD
Cyclosporine—Asthenia—Abacavir—acquired immunodeficiency syndrome	2.84e-05	0.000329	CcSEcCtD
Cyclosporine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	2.84e-05	0.000329	CcSEcCtD
Cyclosporine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000329	CcSEcCtD
Cyclosporine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	2.84e-05	0.000328	CcSEcCtD
Cyclosporine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	2.84e-05	0.000328	CcSEcCtD
Cyclosporine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	2.84e-05	0.000328	CcSEcCtD
Cyclosporine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	2.83e-05	0.000327	CcSEcCtD
Cyclosporine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000327	CcSEcCtD
Cyclosporine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	2.83e-05	0.000327	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	2.82e-05	0.000326	CcSEcCtD
Cyclosporine—ABCB1—central nervous system—acquired immunodeficiency syndrome	2.82e-05	0.000803	CbGeAlD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	2.81e-05	0.00108	CbGpPWpGaD
Cyclosporine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	2.81e-05	0.000325	CcSEcCtD
Cyclosporine—Pruritus—Abacavir—acquired immunodeficiency syndrome	2.81e-05	0.000325	CcSEcCtD
Cyclosporine—Fatigue—Indinavir—acquired immunodeficiency syndrome	2.8e-05	0.000325	CcSEcCtD
Cyclosporine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	2.8e-05	0.000325	CcSEcCtD
Cyclosporine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	2.8e-05	0.000325	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	2.8e-05	0.000324	CcSEcCtD
Cyclosporine—Cough—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000324	CcSEcCtD
Cyclosporine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	2.8e-05	0.000324	CcSEcCtD
Cyclosporine—Pain—Indinavir—acquired immunodeficiency syndrome	2.78e-05	0.000322	CcSEcCtD
Cyclosporine—Constipation—Indinavir—acquired immunodeficiency syndrome	2.78e-05	0.000322	CcSEcCtD
Cyclosporine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000322	CcSEcCtD
Cyclosporine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	2.78e-05	0.000322	CcSEcCtD
Cyclosporine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000322	CcSEcCtD
Cyclosporine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	2.77e-05	0.000321	CcSEcCtD
Cyclosporine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	2.77e-05	0.000321	CcSEcCtD
Cyclosporine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	2.77e-05	0.00032	CcSEcCtD
Cyclosporine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	2.77e-05	0.00032	CcSEcCtD
Cyclosporine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	2.76e-05	0.00032	CcSEcCtD
Cyclosporine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.00032	CcSEcCtD
Cyclosporine—Malaise—Lamivudine—acquired immunodeficiency syndrome	2.76e-05	0.000319	CcSEcCtD
Cyclosporine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	2.75e-05	0.000319	CcSEcCtD
Cyclosporine—Nausea—Didanosine—acquired immunodeficiency syndrome	2.75e-05	0.000319	CcSEcCtD
Cyclosporine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	2.75e-05	0.000318	CcSEcCtD
Cyclosporine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	2.74e-05	0.000318	CcSEcCtD
Cyclosporine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	2.74e-05	0.000317	CcSEcCtD
Cyclosporine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	2.74e-05	0.000317	CcSEcCtD
Cyclosporine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	2.73e-05	0.000316	CcSEcCtD
Cyclosporine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	2.73e-05	0.000316	CcSEcCtD
Cyclosporine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	2.73e-05	0.000316	CcSEcCtD
Cyclosporine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	2.73e-05	0.000316	CcSEcCtD
Cyclosporine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	2.72e-05	0.000315	CcSEcCtD
Cyclosporine—Oedema—Ritonavir—acquired immunodeficiency syndrome	2.72e-05	0.000315	CcSEcCtD
Cyclosporine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	2.71e-05	0.000314	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	2.71e-05	0.000314	CcSEcCtD
Cyclosporine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	2.71e-05	0.000313	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	2.7e-05	0.00104	CbGpPWpGaD
Cyclosporine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	2.7e-05	0.000312	CcSEcCtD
Cyclosporine—FKBP1A—Disease—CCNT1—acquired immunodeficiency syndrome	2.7e-05	0.00104	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MBL2—acquired immunodeficiency syndrome	2.68e-05	0.00103	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	2.68e-05	0.00031	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	2.68e-05	0.00031	CcSEcCtD
Cyclosporine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	2.67e-05	0.000309	CcSEcCtD
Cyclosporine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000309	CcSEcCtD
Cyclosporine—Cough—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000309	CcSEcCtD
Cyclosporine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	2.67e-05	0.000309	CcSEcCtD
Cyclosporine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	2.67e-05	0.000309	CcSEcCtD
Cyclosporine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	2.66e-05	0.000308	CcSEcCtD
Cyclosporine—Dizziness—Stavudine—acquired immunodeficiency syndrome	2.66e-05	0.000308	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	2.66e-05	0.000308	CcSEcCtD
Cyclosporine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.000308	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	2.65e-05	0.000307	CcSEcCtD
Cyclosporine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000307	CcSEcCtD
Cyclosporine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	2.65e-05	0.000307	CcSEcCtD
Cyclosporine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	2.65e-05	0.000307	CcSEcCtD
Cyclosporine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	2.64e-05	0.000306	CcSEcCtD
Cyclosporine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000306	CcSEcCtD
Cyclosporine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	2.64e-05	0.000306	CcSEcCtD
Cyclosporine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	2.63e-05	0.000304	CcSEcCtD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	2.63e-05	0.00101	CbGpPWpGaD
Cyclosporine—Pain—Efavirenz—acquired immunodeficiency syndrome	2.63e-05	0.000304	CcSEcCtD
Cyclosporine—Constipation—Efavirenz—acquired immunodeficiency syndrome	2.63e-05	0.000304	CcSEcCtD
Cyclosporine—Rash—Nevirapine—acquired immunodeficiency syndrome	2.63e-05	0.000304	CcSEcCtD
Cyclosporine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	2.63e-05	0.000304	CcSEcCtD
Cyclosporine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	2.62e-05	0.000304	CcSEcCtD
Cyclosporine—Dizziness—Abacavir—acquired immunodeficiency syndrome	2.62e-05	0.000304	CcSEcCtD
Cyclosporine—Oedema—Saquinavir—acquired immunodeficiency syndrome	2.62e-05	0.000303	CcSEcCtD
Cyclosporine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	2.61e-05	0.000303	CcSEcCtD
Cyclosporine—Headache—Nevirapine—acquired immunodeficiency syndrome	2.61e-05	0.000302	CcSEcCtD
Cyclosporine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000302	CcSEcCtD
Cyclosporine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000302	CcSEcCtD
Cyclosporine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	2.61e-05	0.000302	CcSEcCtD
Cyclosporine—Infection—Saquinavir—acquired immunodeficiency syndrome	2.6e-05	0.000301	CcSEcCtD
Cyclosporine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	2.6e-05	0.000301	CcSEcCtD
Cyclosporine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	2.59e-05	0.0003	CcSEcCtD
Cyclosporine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	2.59e-05	0.0003	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	2.59e-05	0.0003	CcSEcCtD
Cyclosporine—Urticaria—Indinavir—acquired immunodeficiency syndrome	2.58e-05	0.000299	CcSEcCtD
Cyclosporine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.000298	CcSEcCtD
Cyclosporine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	2.57e-05	0.000298	CcSEcCtD
Cyclosporine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	2.57e-05	0.000298	CcSEcCtD
Cyclosporine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	2.57e-05	0.000297	CcSEcCtD
Cyclosporine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	2.57e-05	0.000297	CcSEcCtD
Cyclosporine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.56e-05	0.000297	CcSEcCtD
Cyclosporine—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.56e-05	0.000296	CcSEcCtD
Cyclosporine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.56e-05	0.000296	CcSEcCtD
Cyclosporine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.55e-05	0.000295	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.55e-05	0.00098	CbGpPWpGaD
Cyclosporine—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.55e-05	0.000295	CcSEcCtD
Cyclosporine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Rash—Stavudine—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.54e-05	0.000294	CcSEcCtD
Cyclosporine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.53e-05	0.000293	CcSEcCtD
Cyclosporine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.53e-05	0.000293	CcSEcCtD
Cyclosporine—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.53e-05	0.000293	CcSEcCtD
Cyclosporine—Headache—Stavudine—acquired immunodeficiency syndrome	2.52e-05	0.000292	CcSEcCtD
Cyclosporine—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.52e-05	0.000292	CcSEcCtD
Cyclosporine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.52e-05	0.000292	CcSEcCtD
Cyclosporine—Pain—Delavirdine—acquired immunodeficiency syndrome	2.52e-05	0.000291	CcSEcCtD
Cyclosporine—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.52e-05	0.000291	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.51e-05	0.000291	CcSEcCtD
Cyclosporine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.51e-05	0.000291	CcSEcCtD
Cyclosporine—Rash—Abacavir—acquired immunodeficiency syndrome	2.5e-05	0.000289	CcSEcCtD
Cyclosporine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.5e-05	0.000289	CcSEcCtD
Cyclosporine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	2.5e-05	0.000289	CcSEcCtD
Cyclosporine—Oedema—Lamivudine—acquired immunodeficiency syndrome	2.5e-05	0.000289	CcSEcCtD
Cyclosporine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.5e-05	0.000289	CcSEcCtD
Cyclosporine—Headache—Abacavir—acquired immunodeficiency syndrome	2.48e-05	0.000288	CcSEcCtD
Cyclosporine—Infection—Lamivudine—acquired immunodeficiency syndrome	2.48e-05	0.000287	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.48e-05	0.000287	CcSEcCtD
Cyclosporine—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.48e-05	0.000287	CcSEcCtD
Cyclosporine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.48e-05	0.000287	CcSEcCtD
Cyclosporine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000285	CcSEcCtD
Cyclosporine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.45e-05	0.000284	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	2.45e-05	0.000943	CbGpPWpGaD
Cyclosporine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.45e-05	0.000283	CcSEcCtD
Cyclosporine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000283	CcSEcCtD
Cyclosporine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2.44e-05	0.000283	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.44e-05	0.000938	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.44e-05	0.000938	CbGpPWpGaD
Cyclosporine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.43e-05	0.000281	CcSEcCtD
Cyclosporine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.43e-05	0.000281	CcSEcCtD
Cyclosporine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.43e-05	0.000281	CcSEcCtD
Cyclosporine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	2.42e-05	0.000281	CcSEcCtD
Cyclosporine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.42e-05	0.000281	CcSEcCtD
Cyclosporine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.42e-05	0.00028	CcSEcCtD
Cyclosporine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.41e-05	0.00028	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.4e-05	0.000278	CcSEcCtD
Cyclosporine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.4e-05	0.000278	CcSEcCtD
Cyclosporine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.4e-05	0.000278	CcSEcCtD
Cyclosporine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000277	CcSEcCtD
Cyclosporine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.39e-05	0.000277	CcSEcCtD
Cyclosporine—Nausea—Stavudine—acquired immunodeficiency syndrome	2.39e-05	0.000277	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.38e-05	0.000276	CcSEcCtD
Cyclosporine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000276	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	2.37e-05	0.000913	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	2.37e-05	0.000913	CbGpPWpGaD
Cyclosporine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000274	CcSEcCtD
Cyclosporine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.36e-05	0.000274	CcSEcCtD
Cyclosporine—Nausea—Abacavir—acquired immunodeficiency syndrome	2.36e-05	0.000273	CcSEcCtD
Cyclosporine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.000272	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.35e-05	0.000272	CcSEcCtD
Cyclosporine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.34e-05	0.000271	CcSEcCtD
Cyclosporine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	2.34e-05	0.000271	CcSEcCtD
Cyclosporine—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.33e-05	0.00027	CcSEcCtD
Cyclosporine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	2.33e-05	0.00027	CcSEcCtD
Cyclosporine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.33e-05	0.000269	CcSEcCtD
Cyclosporine—Pain—Ritonavir—acquired immunodeficiency syndrome	2.33e-05	0.000269	CcSEcCtD
Cyclosporine—Constipation—Ritonavir—acquired immunodeficiency syndrome	2.33e-05	0.000269	CcSEcCtD
Cyclosporine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.32e-05	0.000269	CcSEcCtD
Cyclosporine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.32e-05	0.000269	CcSEcCtD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.32e-05	0.000893	CbGpPWpGaD
Cyclosporine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.31e-05	0.000268	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	2.31e-05	0.000888	CbGpPWpGaD
Cyclosporine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000267	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.3e-05	0.000887	CbGpPWpGaD
Cyclosporine—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.3e-05	0.000267	CcSEcCtD
Cyclosporine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000263	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.28e-05	0.000263	CcSEcCtD
Cyclosporine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.26e-05	0.000262	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.26e-05	0.000262	CcSEcCtD
Cyclosporine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000262	CcSEcCtD
Cyclosporine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.26e-05	0.000261	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	2.26e-05	0.000869	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—TAT—acquired immunodeficiency syndrome	2.25e-05	0.000866	CbGpPWpGaD
Cyclosporine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.00026	CcSEcCtD
Cyclosporine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.24e-05	0.000259	CcSEcCtD
Cyclosporine—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.24e-05	0.000259	CcSEcCtD
Cyclosporine—Pain—Saquinavir—acquired immunodeficiency syndrome	2.24e-05	0.000259	CcSEcCtD
Cyclosporine—ABCB1—brain—acquired immunodeficiency syndrome	2.24e-05	0.000637	CbGeAlD
Cyclosporine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.23e-05	0.000258	CcSEcCtD
Cyclosporine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.23e-05	0.000258	CcSEcCtD
Cyclosporine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.22e-05	0.000258	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.22e-05	0.000258	CcSEcCtD
Cyclosporine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.22e-05	0.000257	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—ALB—acquired immunodeficiency syndrome	2.22e-05	0.000854	CbGpPWpGaD
Cyclosporine—SLC10A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.21e-05	0.000849	CbGpPWpGaD
Cyclosporine—Rash—Zidovudine—acquired immunodeficiency syndrome	2.21e-05	0.000255	CcSEcCtD
Cyclosporine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.21e-05	0.000255	CcSEcCtD
Cyclosporine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.2e-05	0.000255	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.2e-05	0.000848	CbGpPWpGaD
Cyclosporine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000255	CcSEcCtD
Cyclosporine—PPIA—Disease—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.000846	CbGpPWpGaD
Cyclosporine—Headache—Zidovudine—acquired immunodeficiency syndrome	2.19e-05	0.000254	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	2.18e-05	0.00084	CbGpPWpGaD
Cyclosporine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.17e-05	0.000252	CcSEcCtD
Cyclosporine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000251	CcSEcCtD
Cyclosporine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.17e-05	0.000251	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.000834	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.000834	CbGpPWpGaD
Cyclosporine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.16e-05	0.00025	CcSEcCtD
Cyclosporine—ABCB1—lymph node—acquired immunodeficiency syndrome	2.16e-05	0.000616	CbGeAlD
Cyclosporine—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	2.16e-05	0.000831	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.00025	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.16e-05	0.00025	CcSEcCtD
Cyclosporine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.15e-05	0.000249	CcSEcCtD
Cyclosporine—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.15e-05	0.000249	CcSEcCtD
Cyclosporine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.000249	CcSEcCtD
Cyclosporine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.000249	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.14e-05	0.000248	CcSEcCtD
Cyclosporine—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.14e-05	0.000247	CcSEcCtD
Cyclosporine—Pain—Lamivudine—acquired immunodeficiency syndrome	2.14e-05	0.000247	CcSEcCtD
Cyclosporine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.11e-05	0.000244	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.00081	CbGpPWpGaD
Cyclosporine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.1e-05	0.000244	CcSEcCtD
Cyclosporine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.08e-05	0.000241	CcSEcCtD
Cyclosporine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.08e-05	0.000241	CcSEcCtD
Cyclosporine—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.08e-05	0.000241	CcSEcCtD
Cyclosporine—ABCC10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.07e-05	0.000799	CbGpPWpGaD
Cyclosporine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.00024	CcSEcCtD
Cyclosporine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.00024	CcSEcCtD
Cyclosporine—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.07e-05	0.00024	CcSEcCtD
Cyclosporine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.06e-05	0.000238	CcSEcCtD
Cyclosporine—Rash—Indinavir—acquired immunodeficiency syndrome	2.05e-05	0.000238	CcSEcCtD
Cyclosporine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.05e-05	0.000237	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.04e-05	0.000236	CcSEcCtD
Cyclosporine—Headache—Indinavir—acquired immunodeficiency syndrome	2.04e-05	0.000236	CcSEcCtD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.04e-05	0.000783	CbGpPWpGaD
Cyclosporine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.03e-05	0.000235	CcSEcCtD
Cyclosporine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.01e-05	0.000233	CcSEcCtD
Cyclosporine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2e-05	0.000232	CcSEcCtD
Cyclosporine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.98e-05	0.00023	CcSEcCtD
Cyclosporine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.97e-05	0.000229	CcSEcCtD
Cyclosporine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.97e-05	0.000229	CcSEcCtD
Cyclosporine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	1.95e-05	0.000226	CcSEcCtD
Cyclosporine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.95e-05	0.000226	CcSEcCtD
Cyclosporine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.94e-05	0.000225	CcSEcCtD
Cyclosporine—Rash—Efavirenz—acquired immunodeficiency syndrome	1.94e-05	0.000224	CcSEcCtD
Cyclosporine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	1.94e-05	0.000224	CcSEcCtD
Cyclosporine—Nausea—Indinavir—acquired immunodeficiency syndrome	1.93e-05	0.000224	CcSEcCtD
Cyclosporine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.93e-05	0.000223	CcSEcCtD
Cyclosporine—Headache—Efavirenz—acquired immunodeficiency syndrome	1.93e-05	0.000223	CcSEcCtD
Cyclosporine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.92e-05	0.000223	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—AGPS—acquired immunodeficiency syndrome	1.91e-05	0.000737	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNA1—acquired immunodeficiency syndrome	1.89e-05	0.000729	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.89e-05	0.000727	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.89e-05	0.000727	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.88e-05	0.000723	CbGpPWpGaD
Cyclosporine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.88e-05	0.000217	CcSEcCtD
Cyclosporine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.87e-05	0.000217	CcSEcCtD
Cyclosporine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.86e-05	0.000215	CcSEcCtD
Cyclosporine—Rash—Delavirdine—acquired immunodeficiency syndrome	1.85e-05	0.000215	CcSEcCtD
Cyclosporine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.85e-05	0.000215	CcSEcCtD
Cyclosporine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.85e-05	0.000214	CcSEcCtD
Cyclosporine—Headache—Delavirdine—acquired immunodeficiency syndrome	1.84e-05	0.000213	CcSEcCtD
Cyclosporine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.84e-05	0.000213	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.84e-05	0.000708	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD79A—acquired immunodeficiency syndrome	1.84e-05	0.000708	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	1.83e-05	0.000706	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CXCR4—acquired immunodeficiency syndrome	1.83e-05	0.000703	CbGpPWpGaD
Cyclosporine—Nausea—Efavirenz—acquired immunodeficiency syndrome	1.83e-05	0.000211	CcSEcCtD
Cyclosporine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.8e-05	0.000208	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000692	CbGpPWpGaD
Cyclosporine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.79e-05	0.000207	CcSEcCtD
Cyclosporine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.79e-05	0.000207	CcSEcCtD
Cyclosporine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.77e-05	0.000205	CcSEcCtD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.76e-05	0.000679	CbGpPWpGaD
Cyclosporine—Nausea—Delavirdine—acquired immunodeficiency syndrome	1.75e-05	0.000202	CcSEcCtD
Cyclosporine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	1.73e-05	0.0002	CcSEcCtD
Cyclosporine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	1.73e-05	0.0002	CcSEcCtD
Cyclosporine—Rash—Ritonavir—acquired immunodeficiency syndrome	1.71e-05	0.000199	CcSEcCtD
Cyclosporine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.71e-05	0.000198	CcSEcCtD
Cyclosporine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.71e-05	0.000198	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.71e-05	0.000657	CbGpPWpGaD
Cyclosporine—Headache—Ritonavir—acquired immunodeficiency syndrome	1.7e-05	0.000197	CcSEcCtD
Cyclosporine—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	1.69e-05	0.000651	CbGpPWpGaD
Cyclosporine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.66e-05	0.000193	CcSEcCtD
Cyclosporine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.65e-05	0.000191	CcSEcCtD
Cyclosporine—Rash—Saquinavir—acquired immunodeficiency syndrome	1.65e-05	0.000191	CcSEcCtD
Cyclosporine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.65e-05	0.000191	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000634	CbGpPWpGaD
Cyclosporine—Headache—Saquinavir—acquired immunodeficiency syndrome	1.64e-05	0.00019	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.62e-05	0.000625	CbGpPWpGaD
Cyclosporine—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.62e-05	0.000187	CcSEcCtD
Cyclosporine—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.61e-05	0.000621	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	1.61e-05	0.000619	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.6e-05	0.000615	CbGpPWpGaD
Cyclosporine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.59e-05	0.000184	CcSEcCtD
Cyclosporine—Rash—Lamivudine—acquired immunodeficiency syndrome	1.57e-05	0.000182	CcSEcCtD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.57e-05	0.000606	CbGpPWpGaD
Cyclosporine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.57e-05	0.000182	CcSEcCtD
Cyclosporine—Headache—Lamivudine—acquired immunodeficiency syndrome	1.56e-05	0.000181	CcSEcCtD
Cyclosporine—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.55e-05	0.00018	CcSEcCtD
Cyclosporine—PPIA—Disease—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.00058	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.5e-05	0.000579	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD40LG—acquired immunodeficiency syndrome	1.5e-05	0.000577	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.5e-05	0.000576	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	1.49e-05	0.000573	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.48e-05	0.000571	CbGpPWpGaD
Cyclosporine—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.48e-05	0.000172	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000571	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD8A—acquired immunodeficiency syndrome	1.48e-05	0.000571	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	1.47e-05	0.000568	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.46e-05	0.000563	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.44e-05	0.000553	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.43e-05	0.000552	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HLA-B—acquired immunodeficiency syndrome	1.43e-05	0.000549	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CXCR4—acquired immunodeficiency syndrome	1.42e-05	0.000545	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	1.39e-05	0.000537	CbGpPWpGaD
Cyclosporine—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.38e-05	0.00053	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	1.37e-05	0.000528	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.37e-05	0.000526	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.36e-05	0.000524	CbGpPWpGaD
Cyclosporine—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.29e-05	0.000498	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.28e-05	0.000492	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.28e-05	0.000492	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.26e-05	0.000487	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	1.25e-05	0.000483	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.000482	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000477	CbGpPWpGaD
Cyclosporine—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	1.18e-05	0.000453	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.17e-05	0.000449	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	1.07e-05	0.00041	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.05e-05	0.000406	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000398	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.92e-06	0.000382	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.92e-06	0.000382	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.73e-06	0.000375	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CCR5—acquired immunodeficiency syndrome	9.71e-06	0.000374	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.59e-06	0.000369	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CD4—acquired immunodeficiency syndrome	9.46e-06	0.000364	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	9.23e-06	0.000355	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	9.06e-06	0.000349	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	9.03e-06	0.000348	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNG—acquired immunodeficiency syndrome	8.82e-06	0.000339	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.81e-06	0.000339	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.77e-06	0.000338	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.58e-06	0.00033	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD4—acquired immunodeficiency syndrome	8.52e-06	0.000328	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.45e-06	0.000325	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	8.24e-06	0.000317	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	8.04e-06	0.00031	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.03e-06	0.000309	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IL6—acquired immunodeficiency syndrome	7.91e-06	0.000304	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD4—acquired immunodeficiency syndrome	7.86e-06	0.000303	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	7.85e-06	0.000302	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2—acquired immunodeficiency syndrome	7.83e-06	0.000302	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	7.58e-06	0.000292	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.55e-06	0.000291	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	7.51e-06	0.000289	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.43e-06	0.000286	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.36e-06	0.000283	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	7.21e-06	0.000278	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	7.01e-06	0.00027	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7e-06	0.000269	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	6.84e-06	0.000263	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.8e-06	0.000262	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.66e-06	0.000256	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.62e-06	0.000255	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.58e-06	0.000253	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	6.44e-06	0.000248	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	6.39e-06	0.000246	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.37e-06	0.000245	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.29e-06	0.000242	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.29e-06	0.000242	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD4—acquired immunodeficiency syndrome	6.1e-06	0.000235	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.98e-06	0.00023	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.54e-06	0.000213	CbGpPWpGaD
Cyclosporine—PPIA—Disease—IL6—acquired immunodeficiency syndrome	5.12e-06	0.000197	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.07e-06	0.000195	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.04e-06	0.000194	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	4.96e-06	0.000191	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	4.94e-06	0.00019	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL6—acquired immunodeficiency syndrome	4.61e-06	0.000177	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	4.45e-06	0.000171	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—IL6—acquired immunodeficiency syndrome	4.25e-06	0.000164	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	4.21e-06	0.000162	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.93e-06	0.000151	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ALB—acquired immunodeficiency syndrome	3.92e-06	0.000151	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	3.76e-06	0.000145	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.62e-06	0.000139	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—acquired immunodeficiency syndrome	3.3e-06	0.000127	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.28e-06	0.000126	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.23e-06	0.000124	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	3.1e-06	0.000119	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.99e-06	0.000115	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.98e-06	0.000115	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	2.95e-06	0.000114	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.94e-06	0.000113	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	2.8e-06	0.000108	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	2.59e-06	9.99e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	2.57e-06	9.9e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.31e-06	8.89e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	1.86e-06	7.16e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	1.68e-06	6.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	1.61e-06	6.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.44e-06	5.53e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	1.4e-06	5.4e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	1.32e-06	5.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.31e-06	5.04e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	8.64e-07	3.33e-05	CbGpPWpGaD
